Volume 29, Issue 4 (December 2025)
Physiol Pharmacol 2025, 29(4): 424-438 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
noory P, Hajmoradi H, Abbasi M, Bahrami N, Ai J. A new accessible source of endometrial mesenchymal stem cells: a promising strategy for liver regeneration and repair in a rat model of chemotherapy-induced injury. Physiol Pharmacol 2025; 29 (4) :424-438
URL: http://ppj.phypha.ir/article-1-2456-en.html
URL: http://ppj.phypha.ir/article-1-2456-en.html
Abstract: (2181 Views)
Introduction: Alkylating agents, commonly used in chemotherapy, can cause significant liver damage by inducing cell death pathways. Human menstrual blood-derived mesenchymal stem cells (HuMenSCs), with their remarkable proliferative capacity and easy accessibility, offer a potential treatment for this injury.
Methods: We investigated the impact of transplanting HuMenSCs in rats using a liver damage model caused by Busulfan injection (36 mg/kg, i.p.). Engraftment was confirmed using fluorescence microscopy and flow cytometry. Hepatic morphology was assessed via histopathological examination. Apoptosis was quantified by TUNEL assay and real-time PCR analysis of apoptotic (Bax) and anti-apoptotic (Bcl2) gene expression.
Results: HuMenSCs effectively engrafted into injured liver tissue. Histopathological examination revealed hepatic morphology significantly improved in the group treated with HuMenSCs, with reduced inflammation, congestion, and sinusoidal dilation. Additionally, both the TUNEL assay and real-time PCR analysis demonstrated a significant decrease in apoptosis and a shift toward the downregulation of pro-apoptotic gene expression (Bax) in the group that received HuMenSCs treatment when compared with the sham (p < 0.0001) and negative control groups (p < 0.001).
Conclusion: The results of our research suggest that HuMenSCs transplantation effectively mitigates Busulfan-induced liver injury by inhibiting apoptosis and promoting liver regeneration. These findings demonstrate the promise of HuMenSCs as a novel therapeutic approach for treating liver damage caused by chemotherapy.
Methods: We investigated the impact of transplanting HuMenSCs in rats using a liver damage model caused by Busulfan injection (36 mg/kg, i.p.). Engraftment was confirmed using fluorescence microscopy and flow cytometry. Hepatic morphology was assessed via histopathological examination. Apoptosis was quantified by TUNEL assay and real-time PCR analysis of apoptotic (Bax) and anti-apoptotic (Bcl2) gene expression.
Results: HuMenSCs effectively engrafted into injured liver tissue. Histopathological examination revealed hepatic morphology significantly improved in the group treated with HuMenSCs, with reduced inflammation, congestion, and sinusoidal dilation. Additionally, both the TUNEL assay and real-time PCR analysis demonstrated a significant decrease in apoptosis and a shift toward the downregulation of pro-apoptotic gene expression (Bax) in the group that received HuMenSCs treatment when compared with the sham (p < 0.0001) and negative control groups (p < 0.001).
Conclusion: The results of our research suggest that HuMenSCs transplantation effectively mitigates Busulfan-induced liver injury by inhibiting apoptosis and promoting liver regeneration. These findings demonstrate the promise of HuMenSCs as a novel therapeutic approach for treating liver damage caused by chemotherapy.
Keywords: Apoptosis, Endometrial mesenchymal, stem cells, Liver regeneration, Hepatotoxicity, Menstrual blood
Type of Manuscript: Experimental research article |
Subject:
Cell, Stem Cell and Cancer
References
1. Ayatollahi M, Hesami Z, Jamshidzadeh A, Gramizadeh B. Antioxidant effects of bone marrow mesenchymal stem cell against carbon tetrachloride-induced oxidative damage in rat livers. International Journal of Organ Transplantation Medicine 2014; 5: 166.
2. Bahirwani R, Reddy K R. Drug-induced liver injury due to cancer chemotherapeutic agents. Seminars in Liver Disease 2014; 34: 162-171. [DOI:10.1055/s-0034-1375957]
3. Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. Journal of Clinical Epidemiology 1993; 46: 1331-1336. [DOI:10.1016/0895-4356(93)90102-7]
4. Borlongan C V, Kaneko Y, Maki M, Yu S-J, Ali M, Allickson J G, et al. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells and Development 2010; 19: 439-452. [DOI:10.1089/scd.2009.0340]
5. Bozorgmehr M, Gurung S, Darzi S, Nikoo S, Kazemnejad S, Zarnani A-H, et al. Endometrial and menstrual blood mesenchymal stem/stromal cells: biological properties and clinical application. Frontiers in Cell and Developmental Biology 2020; 8: 497. [DOI:10.3389/fcell.2020.00497]
6. Cabezas J, Lara E, Pacha P, Rojas D, Veraguas D, Saravia F, et al. The endometrium of cycling cows contains populations of putative mesenchymal progenitor cells. Reproduction in Domestic Animals 2014; 49: 550-559. [DOI:10.1111/rda.12309]
7. Cao L, Yin G, Du J, Jia R, Gao J, Shao N, et al. Salvianolic acid B regulates oxidative stress, autophagy and apoptosis against cyclophosphamide-induced hepatic injury in Nile Tilapia (Oreochromis niloticus). Animals 2023; 13: 341. [DOI:10.3390/ani13030341]
8. Chen L, Xiang B, Wang X, Xiang C. Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure. Stem Cell Research & Therapy 2017a; 8: 1-15. [DOI:10.1186/s13287-016-0453-6]
9. Chen L, Zhang C, Chen L, Wang X, Xiang B, Wu X, et al. Human menstrual blood-derived stem cells ameliorate liver fibrosis in mice by targeting hepatic stellate cells via paracrine mediators. Stem Cells Translational Medicine 2017b; 6: 272-284. [DOI:10.5966/sctm.2015-0265]
10. Ciurea S O, Andersson B S. Busulfan in hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 2009; 15: 523-536. [DOI:10.1016/j.bbmt.2008.12.489]
11. Cui C-H, Uyama T, Miyado K, Terai M, Kyo S, Kiyono T, et al. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Molecular Biology of the Cell 2007; 18: 1586-1594. [DOI:10.1091/mbc.e06-09-0872]
12. De Cesaris V, Grolli S, Bresciani C, Conti V, Basini G, Parmigiani E, et al. Isolation, proliferation and characterization of endometrial canine stem cells. Reproduction in Domestic Animals 2017; 52: 235-242. [DOI:10.1111/rda.12885]
13. Domnina A P, Novikova P V, Lyublinskaya O G, Zenin V V, Fridlyanskaya, II, Mikhailov V M, et al. Mesenchymal stem cells with irreversibly arrested proliferation stimulate decidua development in rats. Experimental and Therapeutic Medicine 2016; 12: 2447-2454. [DOI:10.3892/etm.2016.3671]
14. Dong L, Pu Y, Chen X, Qi X, Zhang L, Xu L, et al. hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. japonicum-infected mice. Stem Cell Research & Therapy 2020; 11: 1-11. [DOI:10.1186/s13287-019-1539-8]
15. Fahmy S R, Amien A I, Abd-Elgleel F M, Elaskalany S M. Antihepatotoxic efficacy of Mangifera indica L. polysaccharides against cyclophosphamide in rats. Chemico-Biological Interactions 2016; 244: 113-120. [DOI:10.1016/j.cbi.2015.11.009]
16. Fang J, Wei H, Wang H, Wang J, Liu H, Chen Y, et al. Human placenta-derived mesenchymal stem cell administration protects against acute lung injury in a mouse model. Journal of Cellular Biochemistry 2023; 124: 1249-1258. [DOI:10.1002/jcb.30445]
17. Floyd J, Mirza I, Sachs B, Perry M C. Hepatotoxicity of chemotherapy. Seminars in Oncology 2006; 33: 50-67. [DOI:10.1053/j.seminoncol.2005.11.002]
18. Fontana R J, Seeff L B, Andrade R J, Björnsson E, Day C P, Serrano J, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010; 52(2):730-42. [DOI:10.1002/hep.23696]
19. Gargett C E, Schwab K E, Deane J A. Endometrial stem/progenitor cells: the first 10 years. Human Reproduction Update 2016; 22: 137-163. [DOI:10.1093/humupd/dmv051]
20. Gargett C E, Schwab K E, Zillwood R M, Nguyen H P, Wu D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biology of Reproduction 2009; 80: 1136-1145. [DOI:10.1095/biolreprod.108.075226]
21. Gazdic M, Simovic Markovic B, Vucicevic L, Nikolic T, Djonov V, Arsenijevic N, et al. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase-and indoleamine 2, 3-dioxygenase-dependent manner. Journal of Tissue Engineering and Regenerative Medicine 2018; 12: 1173-1185. [DOI:10.1002/term.2452]
22. Ghamari A, Daghigh F, Mohebbi A, Rahimi Y, Shojaie L, Zolbin M M. Characteristic and regenerative potential of human endometrial stem cells and progenitors. Stem cells: From Potential to Promise 2021: 55-82. [DOI:10.1007/978-981-16-0301-3_3]
23. Gong W, Wang F, He Y, Zeng X, Zhang D, Chen Q. Mesenchymal stem cell therapy for oral inflammatory diseases: research progress and future perspectives. Current Stem Cell Research & Therapy 2021; 16: 165-174. [DOI:10.2174/1574888X15666200726224132]
24. Grigorian A, O’Brien C B. Hepatotoxicity secondary to chemotherapy. Journal of Clinical and Translational Hepatology 2014; 2: 95. [DOI:10.14218/JCTH.2014.00011]
25. Grochow L B, Jones R J, Brundrett R B, Braine H G, Chen T-L, Saral R, et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemotherapy and Pharmacology 1989; 25: 55-61. [DOI:10.1007/BF00694339]
26. Habibi E, Shokrzadeh M, Chabra A, Naghshvar F, Keshavarz-Maleki R, Ahmadi A. Protective effects of Origanum vulgare ethanol extract against cyclophosphamide-induced liver toxicity in mice. Pharmaceutical Biology 2015; 53: 10-15. [DOI:10.3109/13880209.2014.908399]
27. Heidari N, Mohammadi M, Rezaee M A, Amini A A, Fakhari S, Rahmani M R. Up-regulation of CD200/CD200R1 immunomodulatory axis of allogenic peripheral blood mononuclear cells in a co-culture with adipose-derived mesenchymal stem cells. Iranian Journal of Allergy, Asthma and Immunology 2020; 19: 484-496. [DOI:10.18502/ijaai.v19i5.4464]
28. Hong I-S. Endometrial stem cells: Orchestrating dynamic regeneration of endometrium and their implications in Diverse endometrial disorders. International Journal of Biological Sciences 2024; 20: 864. [DOI:10.7150/ijbs.89795]
29. Hussein M R, Haemel A K, Wood G S. Apoptosis and melanoma: molecular mechanisms. The Journal of Pathology 2003; 199: 275-288. [DOI:10.1002/path.1300]
30. Ishak K G, Zimmerman H J. Morphologic spectrum of drug-induced hepatic disease. Gastroenterology Clinics of North America 1995; 24: 759-786. [DOI:10.1016/S0889-8553(21)00227-2]
31. Jiang W, Liu J, Li P, Lu Q, Pei X, Sun Y, et al. Magnesium isoglycyrrhizinate shows hepatoprotective effects in a cyclophosphamide-induced model of hepatic injury. Oncotarget 2017; 8: 33252-33264. [DOI:10.18632/oncotarget.16629]
32. Jung J, Choi J H, Lee Y, Park J-W, Oh I-H, Hwang S-G, et al. Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4-injured rat liver model via increased autophagic mechanism. Stem Cells 2013; 31: 1584-1596. [DOI:10.1002/stem.1396]
33. Kakizaki M, Yamamoto Y, Nakayama S, Kameda K, Nagashima E, Ito M, et al. Human hepatocyte-derived extracellular vesicles attenuate the carbon tetrachloride-induced acute liver injury in mice. Cell Death & Disease 2021; 12: 1010. [DOI:10.1038/s41419-021-04204-7]
34. Kannan S, Gokul Krishna S, Gupta P K, Kolkundkar U K. Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs. Scientific Reports 2024; 14: 12654. [DOI:10.1038/s41598-024-62544-8]
35. King P D, Perry M C. Hepatotoxicity of chemotherapy. The Oncologist 2001; 6: 162-176. [DOI:10.1634/theoncologist.6-2-162]
36. Kozub M, Prokopiuk V, Skibina K, Prokopiuk O, Kozub N. Comparison of various tissue and cell therapy approaches when restoring ovarian, hepatic and kidney’s function after chemotherapy-induced ovarian failure. Experimental Oncology 2017. [DOI:10.31768/2312-8852.2017.39(3):181-185]
37. Kuçi Z, Bönig H, Kreyenberg H, Bunos M, Jauch A, Janssen J W, et al. Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey. Haematologica 2016; 101: 985. [DOI:10.3324/haematol.2015.140368]
38. Lewis J H. Drug-induced liver disease. Medical Clinics 2000; 84: 1275-1311. [DOI:10.1016/S0025-7125(05)70287-X]
39. Li Q, Yu P, Wang W, Zhang P, Yang H, Li S, et al. Gene expression profiles of various cytokines in mesenchymal stem cells derived from umbilical cord tissue and bone marrow following infection with human cytomegalovirus. Cellular & Molecular Biology Letters 2014; 19: 140-157. [DOI:10.2478/s11658-014-0187-3]
40. Mahmoud A M, Germoush M O, Alotaibi M F, Hussein O E. Possible involvement of Nrf2 and PPARγ up-regulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity. Biomedicine & Pharmacotherapy 2017; 86: 297-306. [DOI:10.1016/j.biopha.2016.12.047]
41. Markovic B S, Gazdic M, Arsenijevic A, Volarevic A, Djonov V, Arsenijevic N, et al. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver NKT cells in IDO dependent manner. Immunome Research 2017; 13: 68.
42. Meng X, Ichim T E, Zhong J, Rogers A, Yin Z, Jackson J, et al. Endometrial regenerative cells: a novel stem cell population. Journal of Translational Medicine 2007; 5: 1-10. [DOI:10.1186/1479-5876-5-57]
43. Meyer S R, Zhang C J, Garcia M A, Procario M C, Yoo S, Jolly A L, et al. A high-throughput microphysiological liver chip system to model drug-induced liver injury using human liver organoids. Gastro Hep Advances 2024;3(8):1045-1053. [DOI:10.1016/j.gastha.2024.08.004]
44. Milosavljevic N, Gazdic M, Simovic Markovic B, Arsenijevic A, Nurkovic J, Dolicanin Z, et al. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Liver Transplantation 2017; 23: 1040-1050. [DOI:10.1002/lt.24784]
45. Mou X-z, Lin J, Chen J-y, Li Y-f, Wu X-x, Xiang B-y, et al. Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells. Journal of Zhejiang University SCIENCE B 2013; 14: 961-972. [DOI:10.1631/jzus.B1300081]
46. Nafees S, Rashid S, Ali N, Hasan S K, Sultana S. Rutin ameliorates cyclophosphamide induced oxidative stress and inflammation in Wistar rats: role of NFκB/MAPK pathway. Chemico-Biological Interactions 2015; 231: 98-107. [DOI:10.1016/j.cbi.2015.02.021]
47. Noory P, Navid S, Zanganeh B M, Talebi A, Borhani-Haghighi M, Gholami K, et al. Human menstrual blood stem cell-derived granulosa cells participate in ovarian follicle formation in a rat model of premature ovarian failure in vivo. Cellular Reprogramming 2019; 21: 249-259. [DOI:10.1089/cell.2019.0020]
48. Olayinka E T, Ore A, Ola O S, Adeyemo O A. Ameliorative effect of gallic acid on cyclophosphamide-induced oxidative injury and hepatic dysfunction in rats. Medical Sciences 2015; 3: 78-92. [DOI:10.3390/medsci3030078]
49. Qiao J, Wu Y, Liu Y, Li X, Wu X, Liu N, et al. Busulfan triggers intrinsic mitochondrial-dependent platelet apoptosis independent of platelet activation. Biology of Blood and Marrow Transplantation 2016; 22: 1565-1572. [DOI:10.1016/j.bbmt.2016.06.006]
50. Rodrigues M C O, Lippert T, Nguyen H, Kaelber S, Sanberg P R, Borlongan C V. Menstrual blood-derived stem cells: in vitro and in vivo characterization of functional effects. Biobanking and Cryopreservation of Stem Cells 2016: 111-121. [DOI:10.1007/978-3-319-45457-3_9]
51. Rodrigues M C O, Voltarelli J, Sanberg P R, Allickson J G, Kuzmin-Nichols N, Garbuzova-Davis S, et al. Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke. Neuroscience & Biobehavioral Reviews 2012; 36: 177-190. [DOI:10.1016/j.neubiorev.2011.05.010]
52. Rollins B J. Hepatic veno-occlusive disease. The American Journal of Medicine 1986; 81: 297-306. [DOI:10.1016/0002-9343(86)90266-4]
53. Ryu C H, Park S A, Kim S M, Lim J Y, Jeong C H, Jun J A, et al. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochemical and Biophysical Research Communications 2010; 398: 105-110. [DOI:10.1016/j.bbrc.2010.06.043]
54. Ryu K-H, Kim S-Y, Kim Y-R, Woo S-Y, Sung S H, Kim H S, et al. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury. Experimental Cell Research 2014; 326: 143-154. [DOI:10.1016/j.yexcr.2014.06.007]
55. Salomone F, Barbagallo I, Puzzo L, Piazza C, Volti G L. Efficacy of adipose tissue-mesenchymal stem cell transplantation in rats with acetaminophen liver injury. Stem Cell Research 2013; 11: 1037-1044. [DOI:10.1016/j.scr.2013.07.003]
56. Santamaria X, Massasa E E, Feng Y, Wolff E, Taylor H S. Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes. Molecular Therapy 2011; 19: 2065-2071. [DOI:10.1038/mt.2011.173]
57. Senior J R. Unintended hepatic adverse events associated with cancer chemotherapy. Toxicologic Pathology 2010; 38: 142-147. [DOI:10.1177/0192623309351719]
58. Shokrzadeh M, Ahmadi A, Naghshvar F, Chabra A, Jafarinejhad M. Prophylactic efficacy of melatonin on cyclophosphamide-induced liver toxicity in mice. BioMed Research International 2014; 2014: 470425. [DOI:10.1155/2014/470425]
59. Sun J. Calcium response to fluid flow-induced mechanotransduction in MC3T3-E1 Cells, mesenchymal stem cells and human osteoblasts. The University of Manchester (United Kingdom), 2014.
60. Tan C Y, Lai R C, Wong W, Dan Y Y, Lim S-K, Ho H K. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Research & Therapy 2014; 5: 1-14. [DOI:10.1186/scrt465]
61. Thatishetty A V, Agresti N, O’Brien C B. Chemotherapy-induced hepatotoxicity. Clinics in Liver Disease 2013; 17: 671-686. [DOI:10.1016/j.cld.2013.07.010]
62. Wei X, Yang X, Han Z-p, Qu F-f, Shao L, Shi Y-f. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacologica Sinica 2013; 34: 747-754. [DOI:10.1038/aps.2013.50]
63. Widholz B, Tsitlakidis S, Reible B, Moghaddam A, Westhauser F. Pooling of patient-derived mesenchymal stromal cells reduces inter-individual confounder-associated variation without negative impact on cell viability, proliferation and osteogenic differentiation. Cells 2019; 8: 633. [DOI:10.3390/cells8060633]
64. Wu X, Luo Y, Chen J, Pan R, Xiang B, Du X, et al. Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous progenitor differentiation in type 1 diabetic mice. Stem Cells and Development 2014; 23: 1245-1257. [DOI:10.1089/scd.2013.0390]
65. Wyllie A. Apoptosis (the 1992 Frank Rose memorial lecture). British Journal of Cancer 1993; 67: 205-208. [DOI:10.1038/bjc.1993.40]
66. Xagorari A, Siotou E, Yiangou M, Tsolaki E, Bougiouklis D, Sakkas L, et al. Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury. International Journal of Clinical and Experimental Pathology 2013; 6: 831.
67. Xiang B, Chen L, Wang X, Zhao Y, Wang Y, Xiang C. Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury. International Journal of Molecular Sciences 2017; 18: 689. [DOI:10.3390/ijms18040689]
68. Yan Y, Xu W, Qian H, Si Y, Zhu W, Cao H, et al. Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver International 2009; 29: 356-365. [DOI:10.1111/j.1478-3231.2008.01855.x]
69. Zhang Z, Wang J-a, Xu Y, Jiang Z, Wu R, Wang L, et al. Menstrual blood derived mesenchymal cells ameliorate cardiac fibrosis via inhibition of endothelial to mesenchymal transition in myocardial infarction. International Journal of Cardiology 2013; 168: 1711-1714. [DOI:10.1016/j.ijcard.2013.03.126]
70. Zhou P, Hohm S, Olusanya Y, Hess D A, Nolta J. Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model. Hepatology 2009; 49: 1992-2000. [DOI:10.1002/hep.22862]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
